Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Saved in:
| Title: | Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. |
|---|---|
| Authors: | Kurata K; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., James-Bott A; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Tye MA; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Graduate School of Arts and Sciences, Cambridge, MA, 02138, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., Yamamoto L; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Samur MK; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tai YT; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Dunford J; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Johansson C; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Senbabaoglu F; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Philpott M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Palmer C; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Ramasamy K; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 7LD, UK., Gooding S; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 7LD, UK., Smilova M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Gaeta G; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Guo M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Christianson JC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK., Payne NC; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, 02138, USA., Singh K; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Bioengineering, Northeastern University, Boston, MA, 02115, USA., Karagoz K; Bristol Myers Squibb, Summit, NJ, 07901, USA., Stokes ME; Bristol Myers Squibb, Summit, NJ, 07901, USA., Ortiz M; Bristol Myers Squibb, Summit, NJ, 07901, USA., Hagner P; Bristol Myers Squibb, Summit, NJ, 07901, USA., Thakurta A; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Bristol Myers Squibb, Summit, NJ, 07901, USA., Cribbs A; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK., Mazitschek R; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Hideshima T; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Teru_Hideshima@dfci.harvard.edu., Anderson KC; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Kenneth_Anderson@dfci.harvard.edu., Oppermann U; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK. Udo.Oppermann@ndorms.ox.ac.uk.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK. Udo.Oppermann@ndorms.ox.ac.uk. |
| Source: | Blood cancer journal [Blood Cancer J] 2023 Jan 12; Vol. 13 (1), pp. 12. Date of Electronic Publication: 2023 Jan 12. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
